13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 25 of 30

Page 25 of 30 – SEC Filing


AFT LP
(a) Amount Beneficially Owned:
By virtue of its ownership of 37.03% of the equity interest in AFT MASTER, AFT LP may be deemed to beneficially own the 465,000 Shares of the Companys Common Stock beneficially owned by AFT MASTER.
(b) Percent of Class:
2.17%
(c) Number of Shares as to which person has:
(i) Sole power to vote or to direct vote:
465,000
(ii) Shared power to vote or to direct vote:
None
(iii) Sole power to dispose or direct disposition of:
465,000
(iv) Shared power to dispose or to direct disposition of:
None
AFT LTD
(a) Amount Beneficially Owned:
By virtue of its ownership of 62.85% of the equity interest in AFT MASTER, AFT LTD may be deemed to beneficially own the 465,000 Shares of the Companys Common Stock beneficially owned by AFT MASTER.
(b) Percent of Class:
2.17%

Page 25 of 30 Pages

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 25 of 30